Traded Volume 127,349 -- VWAP $ 1.42743 -- Dollar Volume $ 181.78k
Not a bad day for a stock that shows:
Outstanding Shares 67,297,500 - 02/28/2018
Restricted - 63,200,000 - 02/28/2018
Unrestricted - 4,097,500 - 02/28/2018
$KVMD looking good now...
Giguiere + Forster + Mitchell = :(
Gannon Giguiere signs a deal with William Mandell of KVMD for 10M shares.
Giguiere accused of Pump-N-Dump with Monarch Bay Securities, LLC... see following link:
Sharon Mitchell lawyer and Gannon CEO of EVTI deal with Monarch Bay. Now Sharon Mitchell is lawyer for KVMD and another S-1 Deal signed with Gannon Giguiere and KVMD. Who is promoting the stock ?
Monarch Bay named in SEC Fraud Complaint with Michael J. Forster a Pump-N-Dump promotor... see link below:
KVMD is another ESSI and EVTI
The following link is legal action against Gannon Giguiere, who's lawyer is Sharon Mitchell, and who's IR person is Mike Hogue. The same group running KVMD. I am concerned with the intelligence of the KVMD CEO and Chairman.
"....the Company engaged in a series of transactions intended to enriching Defendant Gannon Giguiere at the expense of the investing public;"
"On December 15, 2016, a report was published on SeekingAlpha.com alleging that Eco Science was operating a “pump-and-dump scheme” whereby the Company was paying a third party to promote the Company’s stock, inflating the market price."
Who is this third party ? Anyone know ???
S-1 Filed Today
Gannon Giguiere signed agreement with KVMD fo S-1 shares.
Sharon Mitchell, lawyer, prepared KVMD S-1. She prepared Gannan Giguiere's ESSI and EVTI S-1. Both companies defunked.
Mike Hogue was hired by KVMD to promote stock. Mike Hogue promoted ESSI.... now Caveat Emptor. Gannon did a Pump and Dump with EVTI and ESSI while Sharon Mitchel and Mike Hogue assisted. LOL
Very cheap shares.
Hey.... I'm just the messenger here.
Gannon, Hogue and Sharon did a pump and dump with ESSI. I only provided the link to the criminal case filed.
Now Sharon sold her 3M KVMD shares, and the CEO & Chairman signed an S-1 Agreement with Gannon, and an IR Agreement with Hogue as disclosed in the 10-Q filed on 2/5/2018.
So this is peeps according to you ? LMFAO
KVMD Revenues and Product Development
The 10-Q could only state the following;
1. The company is working out of the CEO and Chairman's living room!
"The address of our principal executive office is 10930 Skyranch Place, Nevada City, CA 95959 . Our telephone number is (530) 388-8706."
2. KVMD sold nothing to someone to show revenue of $120. This was probably required to demonstrated to FINRA the S-1 Filing was for a company with product sales.
"As of December 31, 2017 and June 30, 2017 the Company has received a customer deposit of $120 in respect to the sale of three units of the Therm-N-Ice arm band. The deposit represents a one-third deposit for each of the three units ordered."
3. The Chairman and CEO are taking money from their other company (OMS) each month to license their patent to KVMD, and there are still no revenues because they haven't built any products or received a 510k exemption from the FDA.
"The Company accrues patent license fees in respect to a patent license agreement with Oasis Medical Solutions (ref: Note 3 above). As at December 31, 2017 and June 30, 2017 a total $5,583 and $4,583 remained payable under the terms of this agreement, respectively. A total of $3,500 was incurred as new charges in the period ended December 31, 2017 (2016 - $3,500) and the Company paid a total of $2,500 to reduce the outstanding account (2016 - $nil)."
4. Ineffective Control Procedures
Based on the foregoing, our president and chief financial officer (our principal executive officer, principal financial officer and principal accounting officer) concluded that our disclosure controls and procedures were not effective as of the end of the period covered by this quarterly report.
5. No revenue. No product development.
We did not earn any income in the six months ended December 31, 2017 and 2016. We continue to incur administrative costs related to the execution of our business plan. Professional fees including legal fees, audit and accounting and Edgar filing fees totaled $24,500 during the six months ended December 31, 2017 and $nil in the same period ended December 31, 2016. The substantive increase in expenditures period over period is due to the fact that in the prior comparative period the Company had only recently filed its initial offering documents on Form S-1, the costs for which were included as a flat fee expensed in a subsequent period. In addition, during the six months ended December 31, 2017 we incurred patent license fees of $3,500, and management fees of $6,000, which costs were unchanged from the costs incurred in the prior comparative six month period in 2016. General and administrative costs were $3,140 and $30 respectively in the six months ended December 31, 2017 and 2016.
10-Q Disclosure of Share Sales
During the six months ended December 31, 2017 the Company received proceeds from a private placement of 3,000,000 shares at $0.03 per share of $90,000 as well as net advances of $4,125 from a related party as compared to only $3,060 in advances from a related party in the prior comparative period.
Where did the 3,000,000 shares come from ? Only Sharon Mitchell was holding 3,000,000 shares. Who purchased them?
The share price jumped from $.02 to over $1.00.
Did Phenix Ventures, LLC / Gannon Giguiere aquire 3M shares from Sharon Mitchell/S-1 Consulting Services, LLC ?
Is Mike Hogue pumping news for Gannon ?
Now we can meet Sharon Mitchell
Sharon Mitchell (i.e., (the "Consultant"), S-1 Consulting LLC, and
SD Mitchell & Associates, PLC
829 Harcourt Rd.
Grosse Pointe Park, MI, 48230
On October 23, 2017, the Company entered into a one-year agreement with a consultant for advice regarding certain legal, corporate and business operations, and more specifically with regard to public filings and compliance with regard to the Company. The consultant is to be compensated in the amount of Two Thousand Dollars ($2,000) per month, commencing November 1, 2017, including review of Form 10-K Annual Reports, Form 10-Q Quarterly Reports, Preparation of Form 8-K's, preparation of Board Resolutions and review of contractual agreements.
Lawyer for EVTI, ESSI, AWSL and GRNO. All DEFUNCT !
Close with Gannon Giguiere
Working on multiple S-1 Filings
Let's discuss Mike Hogue
On January 1, 2018, the Company entered into a one-year agreement with a consultant for advice regarding certain investor relations. The Consultant is to be compensated in the amount of One Thousand Dollars ($1,000) per month, commencing January 1, 2018, along with the issuance of 100,000 shares of Kelvin's Common Stock. At the date of this report, those shares have not yet been issued.
Eco Science Solutions, Inc. OTCBB: ESSI OTCBB data delayed by 15 mins Currency in USD
Investor Relations Mike Hogue
Eco Science Solutions, Inc.
So, now you know that Mike Hogue works closely with Gannon Giguiere and Sharon Mitchell (the "Consultant)/Lawyer.
Let's start with Gannon Giguiere
Gannon is the principal of PHENIX VENTURES, LLC
On January 22, 2018, the Company entered into an Equity Purchase Agreement ("EPA"), and Registrations Rights Agreement with a Third Party, Phenix Ventures, LLC, wherein, Phenix Ventures has committed to purchasing 10,000,000 shares of the Company's Common Stock. Phenix will not hold any more than 9.99% of the issued and outstanding shares at any one time and funding will come by way of Put Notices as outlined in the EPA. WHEREAS, upon the terms and subject to the conditions of the Equity Purchase Agreement ("Purchase Agreement"), between the Investor and the Company, the Company has agreed to issue and sell to the Investor up to ten million (10,000,000) shares (the "Put Shares") of its common stock, $0.001 par value per share (the "Common Stock") from time to time. for an aggregate investment price of up to Fifteen Million Dollars ($15,000,000) (the "Registered Securities");
As CEO, Gannon destroyed ESSI and EVTI. He is a stock promoter who is now doing an S-1 Reg with FINRA.
He works closely with Sharon Mitchel (the "Consultant")/lawyer, who is the lawyer for ESSI, EVTI and now KVMD !!! Beware.
Ok. You got me here!
Yes, reading is handy.
The KVMD S-1 was approved by FINRA at 2 cents a share.
It quickly increased. In my opinion, the evidence of a single seller who weeded the stock into the market.
Show me an S-1 approved by FINRA with a company that has no product, no office, and no sales?
The stock is now over priced based upon the trading activity in the past 90 days. This is a huge red flag.
KVMD website says different.
The website states that they develop and sell medical products. Yet, they have no medical products to sell. In fact, they have no office, nor any infrastructure to even develop a product. The only two officers of the company have full time jobs elsewhere. One is a therapist in Nevada City, California, and the other woks for Eigen, Inc. in Grass Valley, California. The S-1 states that they are married, yet they both have different last names. This, in itself, demonstrates that they are deceitful individuals.
The S-1 states that they are raising money to build their first product. Hopefully the 10-Q will be filed shortly and we can see if they have any money or have made any progress to make this a real company.
Right now someone has dumped 1M-3M shares into the market, and in my opinion looks like a royal fleecing to the shareholders. It's about the same number of shares that were given to the lawyer, Sharon Mitchell of S-1 Consulting, LLC, as stated in the S-1.
My argument is that there is contradictive disclosure.
How is this for transparency?
development stage companies, do not have assets. Development stage companies usually have convertible debt and hundreds of millions of shares O/S.
This has neither, why you would pick this stock as the one to disparage is something that only you could answer.
The company has been transparent...can't wait to hear the same from you.
I will remain here for the duration.
There are two sides to each opinion. My opinion remains the same.
The company S-1 has disclosed facts related to a company with no assets and no products to sell.
The stock price has been inflated.
this is where reading comes in handy:
I never said that stock wasn't being sold...in fact I think it is well known by ALL investors that if there is a trade..then someone sold and someone bought.
The company said that they were trying to sell S1 registered stock. This was never hidden
If you'd rather move to a stock with 1Bn o/s, please do so. This one has 100mil a/s and only 4mil o/s with 30mil in the S1.
If you don't like it, then move on.
I disagree. S-1 Stock is being sold.
The only way for shares to have been sold into this market was through the subscription shareholders in the S-1. Sharon Mitchel (i.e., S-1 Consultants LLC) prepared the S-1 and was paid with 3M shares. Is it possible that she sold these shares to an investor, or the subscribers have sold or deposited stock?
These shares were fully disclosed:
The Company has authorized 100,000,000 shares with par value of $0.001.
Effective May 15, 2016 the Company issued 30,000,000 shares of common stock as a signing bonus valued at $30,000 or $0.001 per share, to our President, Mr. William Mandel.
Effective May 15, 2016 the Company issued 30,000,000 shares of common stock as a signing bonus valued at $30,000 or $0.001 per share, to our Chairman, Dr. Margaret Austin.
Effective June 1, 2016 the Company issued 3,000,000 shares of common stock in respect to the S-1 Services agreement valued at $60,000 or $0.02 per share (ref: Note 4).
This was in the SEC.gov filing of: "Filing Date 2017-05-15"
nothing is being withheld from investors other than the motive of those bashing...
Where are the Form's 3, 4 & 5????
The S-1 indicates 3M shares used to pay Sharon Micthell, lawyer, to prep the S-1. The husband and wife scam team took 60M. How did FINRA approve the valuation of 60M shares ??? No sales, no product, no patent !How did the auditor create an asset? Based on what ?
Number of Shares Outstanding Before the Offering
There are 63,000,000 shares of Common Stock issued and outstanding as of the date of this prospectus; 30,000,000 held by our President, Chief Executive Officer, Secretary, Treasurer, and Director, Mr. William Mandel, and 30,000,000 held by our Chairman of the Board, Dr. Margaret Austin, PhD. 3,000,000 shares have been issued to a consultant for services rendered with regard to this Registration Statement.
I bet the lawyer sold her shares at 2 cents to some slick investor.... now dumping.
No product. No sales. No patent. No office. Virtual Management.....
Driving market growth:
The U.S. represents the largest market worldwide. Asia-Pacific ranks as the fastest growing market with a CAGR of 9.4% through the analysis period, led by factors such as growing population and healthcare burden; consumer demand for affordable, safe and non-invasive therapies for pain management; stringent workplace safety and health regulations and the resulting pressure on employers to provide workers
with easy access to safety and first aid supplies to treat injuries and prevent aggravation and exacerbation.
Is there a market for a portable, easy to use and singular product (i.e. provides both heat and cold treatments)?
We'll find out.
I did a search on "hot and cold therapy products" and there are a lot of them but if you'll notice on this site:
Almost NONE of them are very portable and NONE of them combine portability within a single product for both "hot" and "cold".
Global market for Hot and Cold Therapy Packs is projected to reach US$1.3 Billion by 2024, driven by the elderly who are most vulnerable to pain and injury, and the ongoing shift in medical care towards non-hospital settings.
The market is also poised to benefit from the growing economic and social burden of workday injuries and musculoskeletal pain. Poor posture, repetitive movements and prolonged immobilization are key factors responsible for the rising incidence of musculoskeletal disorders and pain. Among the aging population, pain caused by chronic rheumatic conditions such as rheumatoid arthritis, osteoarthritis, osteoporosis, spinal disorders and severe limb trauma, is driving demand for drug free pain management therapies like hot and cold therapy packs.
Hit my scanner end of November. Grabbed some as accum was increasing. No brainer from a trading stand point.
How did all you hear about this stock? I have been watching it for a while and all of a sudden y'all showed up. Its refreshing to see a new pump and dump was a pleasure watching orrv go down
Yes , all an illusion that the share price has gone from .50 to over 1.00 in a short period of time.
Trading tickers here, not looking at fundamentals of an OTC ticker.
Its a penny stock. Lmao
I don't care if they say they sell animal crackers. I trade to make money.
No money here to take. lol
I'm still puzzled how a husband and wife who have full time jobs elsewhere can find time to scam the public with a company that has no office, no product, no sales, no asset, no IP..... LOL
The trading is an illusion.
The company website states "Kelvin Medical Inc. is a recently organized company that engages in the development and sale of medical devices."
There are no products and no sales. There will be no products and no sales for a year or more considering the fact that the S-1 was organized to raise the money to built the first inventory, and only if the FDA issues a 510k, and they have the money or distribution channel to sell products. The therapy market is saturated with low cost modalities at very low cost. The healthcare market is painfully struggling to keep afloat with high expenses and low insurance payments. KVMD would need $10M and a real infrastructure to earn the privilege to play in the medical device market, littles prove sales. CMS takes 2 years to establish a billing code so doctors can get reimbursed for the product. No one will be able to afford to buy it even if they wanted it! They are no where near the playing field.
The 10-Q ending 12/31/17 is due soon. Let's see what money has come in to build product. They can't even get through the FDA for the 510k without product, and that process takes 6 months!!!
Come'on people!!! Another worthless penny stock scam.
Yes, Just started dumping.
Obviously the 3M shares held by Sharon Mitchell the lawyer for slapping together a cookie-cutter S-1 were sold to some investor for 2 cents. She gets her $60K and the investor dumps the paper in the market through the market maker Glendale Securities. I have no problem with this, as this is a routine procedure for these penny's. My problem is that there are no revenues, no products, no company, no facility, and no management working full time. The future is grim. Very grim. Buying a 2 cent stock for over a dollar with no revenue on the horizon is not fundamentally smart. How did Glendale Securities get FINRA approval to do the S-1 on a company with no revenue, no infrastructure, no product, no full time management, no asset etc..... ????? This seems very out of the norm for today's regulatory environment.